Per Editor: Peng Shuiping
In the late session of December 15, WuXi AppTec, a pharmaceutical leader with a market value of 370 billion, plunged to a halt near the end of the A-share market, and WuXi AppTec's Hong Kong stock fell by more than 15%. As of the close of A-shares, WuXi AppTec failed to open the stop price of 124.02 yuan, and the volume of transactions throughout the day reached 6.418 billion yuan.
Image source: Photo.com - 401696359
At the same time, Hong Kong-listed biomedical stocks plunged collectively, with WuXi Biologics falling nearly 20%, Clover Falling more than 18%, and Rongchang Biologics falling 14%. The anti-epidemic sector also fell collectively, with Pioneering Pharmaceutical falling more than 8%, Junshi Bio falling more than 7%, Ping An Good Doctor and Fosun Pharma falling more than 6%, China Biopharmaceutical falling nearly 5%, and JD Health falling more than 3%.
Today' pharmaceutical stocks have become the focus of market attention, first of all, the new pharmaceutical stocks with an issue price of nearly 200 yuan have broken, followed by the pharmaceutical stocks led by WuXi AppTec in the end of the A-share market and the collective diving of Hong Kong stocks, and finally WuXi AppTec A shares closed at a stop price of 124.02 yuan, and the total market value of the day shrank by more than 40 billion yuan to 366.6 billion yuan.
For the tail plate flash crash of WuXi AppTec, some netizens expressed their confusion about "what is the situation under the explanation of the study committee", and some shareholders lamented that "I bought it the day before yesterday, I was greedy, and I directly ate the fall stop today" "I just wanted to go and smash the fall stop". However, there are also netizens who shout that the bottom is "the opportunity to increase the position".
According to the latest news from the Financial Associated Press, for the drug name Condor A shares and H shares fell sharply at the same time, WuXi AppTec relevant people replied to reporters that the current operation of the company is normal.
Source: Daily Economic News Comprehensive Public Information, Financial Associated Press
(Disclaimer: The content and data in this article are for reference only and do not constitute investment advice, and are verified before use.) Do so at your own risk. ）
Daily economic news